{"disease":{"id":"imatinib-mesylate","name":"imatinib mesylate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00702689","title":"Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}